Menu

CEL-SCI Corporation CVM

Full chart Compare
Set alert

Price alert · CVM

All alert types
1.35 USD -0.10 (-6.90%)

At closeNov 9, 2026, 5:05 PM EST

1.39 +0.04 +2.96%

After hours · Nov 9, 5:05 PM ET

1.35 Day range 1.53
0.89 52-week range 7.80
YTD
-74.33%
1 year
-80.82%

Discussion (163)

Sign in to join the discussion

alsp@qx.net CVM 2 years ago #61

Let’s face it. The FDA is controlled by big pharma and they are not going to let a nothing company like $CVM bring a blockbuster cancer therapy to market. I used to treat H&N cancer. MK should have been approved long ago (proven efficacy- ZERO toxicity) if not for its inept/corrupt (what’s the difference) CEO. Patience will be rewarded , but likely with acquisition at $30-$40 dollars instead of $150-$200/s an independent $CVM would bring.

alsp@qx.net CVM 2 years ago #62

Let’s face it. We have invested in a company with an inept - perhaps corrupt - CEO. Why no shareholder update? Why no explanation regarding presence - or lack thereof - at JPM Health Conference? Remember the years wasted by poor oversight of company overseeing testing during early part of patient trials. Yes, testing company sued but YEARS wasted. Just one stumble/delay after another with no accountability to shareholders.

alsp@qx.net CVM 2 years ago #63

Saw Amgen CEO on Cramer. Why does small cell cancer drug gets ‘breakthrough therapy’ designation but Mk - with efficacy and ZERO toxicity - get ignored. Is it all about money with the FDA or perhaps they have a real CEO. No way at this point should Geert not have someone’s ear at the JPM Healthcare Conference. I have known about MK since 1990. This has all taken way too long. MK, cancer patients and investors deserve much better.

alsp@qx.net CVM 2 years ago #64

Why isn’t Geert going to the press and questioning why governing bodies are denying cancer patients a new and effective treatment with ZERO side effects? Why are any further studies needed for a drug that has shown increased 5 year survival in terminal patients that has no toxicity? Who is being harmed by approval of such (a drug? I will tell you - companies like MERCK that want their own cancer drug -Keytruda- to (hopefully) show some eefficacy

alsp@qx.net CVM 2 years ago #65

Anyone have any idea if Geert is at the JP Morgan healthcare conference trying to promote his company to investors? Seems this is something a biotech CEO should be doing

alsp@qx.net CVM 2 years ago #66

How has Geert lasted so long? Is there really a Board of Directors?

alsp@qx.net CVM 2 years ago #67

Hopefully just profit taking by people who just don’t get it. When I see ‘Fibonacci’ and other trading terms used with $CVM I am reminded how many short sighted people are trading this stock. Moving in an out of a few hundred shares might get you a weekend in a nice hotel. But holding on to a few thousand shares will get you a vacation home. How will you feel when you wake up and the 500s you sold at a 10 cent profit opens up at $40? And if you short this stock you may end up having to sell your home

alsp@qx.net CVM 2 years ago #68

This kind of movement will draw more attention to the stock. FOMO? Might see another pop tomorrow.

alsp@qx.net CVM 2 years ago #69

Is there really a BOD for $CVM? I don’t see how Geert has lasted so long.

alsp@qx.net CVM 2 years ago #70

Would be dumb to sell. Sign distribution agreement. $125